Literature DB >> 23257023

Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.

Pavel Zhabyeyev1, Manoj Gandhi, Jun Mori, Ratnadeep Basu, Zamaneh Kassiri, Alexander Clanachan, Gary D Lopaschuk, Gavin Y Oudit.   

Abstract

AIMS: Development of heart failure is known to be associated with changes in energy substrate metabolism. Information on the changes in energy substrate metabolism that occur in heart failure is limited and results vary depending on the methods employed. Our aim is to characterize the changes in energy substrate metabolism associated with pressure overload and ischaemia-reperfusion (I/R) injury. METHODS AND
RESULTS: We used transverse aortic constriction (TAC) in mice to induce pressure overload-induced heart failure. Metabolic rates were measured in isolated working hearts perfused at physiological afterload (80 mmHg) using (3)H- or (14)C-labelled substrates. As a result of pressure-overload injury, murine hearts exhibited: (i) hypertrophy, systolic, and diastolic dysfunctions; (ii) reduction in LV work, (iii) reduced rates of glucose and lactate oxidations, with no change in glycolysis or fatty acid oxidation and a small decrease in triacylglycerol oxidation, and (iv) increased phosphorylation of AMPK and a reduction in malonyl-CoA levels. Sham hearts produced more acetyl CoA from carbohydrates than from fats, whereas TAC hearts showed a reverse trend. I/R in sham group produced a metabolic switch analogous to the TAC-induced shift to fatty acid oxidation, whereas I/R in TAC hearts greatly exacerbated the existing imbalance, and was associated with a poorer recovery during reperfusion.
CONCLUSIONS: Pressure overload-induced heart failure and I/R shift the preference of substrate oxidation from glucose and lactate to fatty acid due to a selective reduction in carbohydrate oxidation. Normalizing the balance between metabolic substrate utilization may alleviate pressure-overload-induced heart failure and ischaemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257023     DOI: 10.1093/cvr/cvs424

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  39 in total

Review 1.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

2.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

Review 3.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 4.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 5.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

6.  Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

Authors:  Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2016-03-10       Impact factor: 10.787

7.  Metabolic Therapy in Heart Failure.

Authors:  Yury Lopatin
Journal:  Card Fail Rev       Date:  2015-10

8.  Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

Authors:  Kim L Ho; Liyan Zhang; Cory Wagg; Rami Al Batran; Keshav Gopal; Jody Levasseur; Teresa Leone; Jason R B Dyck; John R Ussher; Deborah M Muoio; Daniel P Kelly; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

9.  Remodeling of substrate consumption in the murine sTAC model of heart failure.

Authors:  Aslan Turer; Francisco Altamirano; Gabriele G Schiattarella; Herman May; Thomas G Gillette; Craig R Malloy; Matthew E Merritt
Journal:  J Mol Cell Cardiol       Date:  2019-07-21       Impact factor: 5.000

10.  Mitochondrial dysfunction and its impact on diabetic heart.

Authors:  Suresh Kumar Verma; Venkata Naga Srikanth Garikipati; Raj Kishore
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-09-01       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.